| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | TELA Tela Bio, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 315,000 | $8.00 | $2,520,000.00 | +18.7% | -2.6% | +10.7% | |
| Aug 16, 2022 | RGEN Repligen Corp | Snodgres Jon59 | Chief Financial Officer | Sell | 6,698 | $252.86 | $1,693,688.60 | -8.6% | -20.5% | -33.4% | |
| Aug 16, 2022 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 116 | $24.81 | $2,877.96 | -0.3% | -8.4% | -54.0% | |
| Aug 16, 2022 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 914 | $21.48 | $19,632.72 | -0.3% | -15.0% | -30.8% | |
| Aug 16, 2022 | SIBN Si-Bone, Inc. | Francis Laura70 | Chief Executive Officer | Sell | 5,248 | $17.29 | $90,723.23 | -0.3% | -20.2% | +20.1% | |
| Aug 16, 2022 | SONX Sonendo, Inc. | Smith Michael John | Chief Commercial Officer | Sell | 7,224 | $1.48 | $10,657.57 | -2.1% | - | - | |
| Aug 16, 2022 | OM Outset Medical, Inc. | Vazquez Martin84 | Chief Operating Officer | Sell | 260 | $21.48 | $5,584.80 | -0.5% | -15.0% | -30.8% | |
| Aug 16, 2022 | AORT Artivion, Inc. | Maney Rochelle L. | VP, Quality | Sell | 7,161 | $22.96 | $164,409.40 | -36.7% | -46.0% | -30.2% | |
| Aug 16, 2022 | NVNO Envveno Medical Corp | Duhay Francis | Director | Buy | 7,751 | $6.14 | $47,591.14 | +58.9% | +4.8% | -15.2% | |
| Aug 16, 2022 | SIBN Si-Bone, Inc. | Maheshwari Anshul67 | Chief Financial Officer | Sell | 1,709 | $17.29 | $29,543.82 | -0.9% | -20.2% | +20.1% | |
| Aug 16, 2022 | AHCO Adapthealth Corp. | Joyce Christopher J46 | General Counsel | Sell | 100,000 | $22.20 | $2,219,530.00 | -48.5% | -0.4% | -38.8% | |
| Aug 16, 2022 | SIBN Si-Bone, Inc. | Pisetsky Michael A68 | SVP, Ops &Adm/ Chief Legal Ofr | Sell | 3,475 | $17.29 | $60,073.02 | -0.7% | -20.2% | +20.1% | |
| Aug 16, 2022 | SONX Sonendo, Inc. | Watts Michael Patrick | Chief Financial Officer | Sell | 5,186 | $1.48 | $7,650.91 | -2.2% | - | - | |
| Aug 16, 2022 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 351 | $21.48 | $7,539.48 | -1.0% | -15.0% | -30.8% | |
| Aug 16, 2022 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 5,463 | $17.29 | $94,439.97 | -0.8% | -20.2% | +20.1% | |
| Aug 16, 2022 | NXGL Nexgel, Inc. | Stefansky David54 | Director | Buy | 5,372 | $1.85 | $9,946.28 | +19.7% | -29.6% | +8.3% | |
| Aug 15, 2022 | RMD Resmed Inc | Farrell Michael J.63 | Chief Executive Officer | Sell | 5,675 | $238.09 | $1,351,165.86 | -1.4% | -6.5% | -22.4% | |
| Aug 15, 2022 | CERS Cerus Corp | Menard Chrystal71 | Chief Legal Officer | Sell | 10,000 | $5.18 | $51,800.00 | -5.7% | -24.4% | -63.9% | |
| Aug 15, 2022 | BDX Becton Dickinson & Co | Hickey David56 | EVP &President, Life Sciences | Sell | 475 | $265.00 | $125,875.00 | -12.5% | -15.7% | +6.4% | |
| Aug 15, 2022 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Chairman &CEO | Sell | 19,875 | $104.74 | $2,081,772.22 | -3.6% | -29.8% | -23.8% | |
| Aug 15, 2022 | BDX Becton Dickinson & Co | Polen Thomas E Jr | Chairman, CEO And President | Sell | 9,500 | $265.13 | $2,518,735.00 | -24.8% | -15.7% | +6.4% | |
| Aug 15, 2022 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 1,700 | $175.04 | $297,568.00 | -3.0% | +10.8% | +48.9% | |
| Aug 15, 2022 | HYPR Hyperfine, Inc. | Gupta Alok | Chief Financial Officer | Sell | 8,871 | $1.45 | $12,862.95 | -7.0% | -38.0% | +53.3% | |
| Aug 15, 2022 | HAE Haemonetics Corp | Kroll Mark W | Director | Sell | 8,016 | $73.71 | $590,859.36 | -33.1% | +2.3% | +22.3% | |
| Aug 15, 2022 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 30,000 | $19.27 | $578,062.77 | -2.6% | -36.0% | -63.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.